VANCOUVER, BC / ACCESSWIRE / April 27, 2017 / Zinc One Resources Inc. (TSXV: Z) (OTC Pink: ZZZOF) (FSE: RH33) (“Zinc One or the Company”) is pleased to announce that Forrester Metals Inc. (“Forrester”) has appeared before the Ontario Superior Court of Justice and has received approval to proceed with the Plan of Arrangement with Zinc One, pursuant to which Zinc One will acquire all of the issued and outstanding common shares of Forrester (the “Arrangement”). The Arrangement is subject to Zinc One completing a private placement financing of $10,000,000. Upon this condition precedent being fulfilled and following receipt of TSX Venture and NEX approval for the transaction, the transaction will close.

Receives DTC Eligibility

The Company would also like to announce it has obtained DTC eligibility with the Depository Trust Company for its common shares in the United States. The Depository Trust Company (“DTC”) is a subsidiary of the Depository Trust & Clearing Corp. and manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered DTC eligible. This electronic method of clearing securities speeds up the receipt of shares and cash, and thus generally accelerates the settlement process for investors. The ability to have Zinc One’s shares trade electronically in the US provides greater convenience for investors and lowers the costs incurred in buying and selling shares. Benefits to Zinc One shareholders as a result of becoming DTC eligible include reducing the time for stock deposits and withdrawals into brokerage accounts as well as opening up access to trade Zinc One shares electronically that was not available prior to DTC approval, creating a significantly larger potential investor base.

About Zinc One Resources Inc.

Zinc One is a Vancouver based company focused on the acquisition, exploration and development of prospective and advanced zinc projects. Zinc One believes in the current and future fundamentals of the zinc supply and demand scenario and the continued growing demand for zinc in global industrial uses.

For more information, please contact James Walchuck, CEO and President at (604) 683-0911.

ON BEHALF OF THE BOARD OF DIRECTORS OF

ZINC ONE RESOURCES INC.

“signed”

James Walchuck
CEO and President

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Zinc One cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond their respective control. Such factors include, among other things: risks and uncertainties relating to Zinc One’s limited operating history, ability to complete the proposed transaction with Forrester (including obtaining all necessary regulatory approvals), ability to close the private placement financing and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Zinc One does not undertake to publicly update or revise forward-looking information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zinc One Resources Inc.

ReleaseID: 460784

Upcoming AWS Coverage on Dover Post-Earnings Results

LONDON, UK / ACCESSWIRE / April 27, 2017 / Active Wall St. announces its post-earnings coverage on Illinois Tool Works Inc. (NYSE: ITW). The Company released its first quarter fiscal 2017 results on April 24, 2017. The Industrial tool maker surpassed top- and bottom-line expectations. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Illinois Tool Works’ competitors within the Diversified Machinery space, Dover Corp. (NYSE: DOV), released its Q1 quarter 2017 earnings results on Thursday, April 20, 2017. AWS will be initiating a research report on Dover in the coming days.

Today, AWS is promoting its earnings coverage on ITW; touching on DOV Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings and Operating Results

For the quarter ended March 31, 2017, Illinois Tool’s revenue grew 6.0% to $3.47 billion compared to revenue of $3.27 billion in Q1 2016. The Company’s organic revenue increased 3.5% in the reported quarter while the 2016 acquisition of Engineered Fasteners & Components (EF&C) added 3.8% to revenue, offset by foreign currency impact which reduced revenue by 1.3%. Illinois Tool’s revenue numbers exceeded analysts’ consensus of $3.40 billion.

For Q1 2017, Illinois Tool’s operating income was $809 million, an increase of 12% on a y-o-y basis, the highest quarterly total in the Company’s 105-year history. Illinois Tool’s operating margin for the reported quarter was 23.3%, up 120 basis points compared to the year ago same period. Excluding the margin impact from the 2016 acquisition of EF&C, operating margin was 23.8%, an increase of 170 basis points y-o-y with 100 basis points of structural margin improvement from Enterprise Initiatives. The Company’s after-tax return on invested capital was 23.8%, an improvement of 260 basis points.

For Q1 2017, Illinois Tool’s reported earnings of $536 million compared to earnings of $468 million in Q1 2016. On a per-share basis, the Glenview, Illinois-headquartered Company reported earnings of $1.54, up 19% compared to earnings of $1.29 million in the year ago comparable period. Earnings results topped Wall Street’s expectations of $1.45 per share.

Segment Results

For Q1 2017, Illinois Tool’s Automotive OEM revenue surged 26% to $828 million, the segment delivered above-plan organic revenue growth of 9%, 300 basis points above global car builds. In North America, Automotive OEM’s 4% organic growth exceeded auto builds of 3% overall and 1% for the Detroit. Outside North America, growth remained strong, with Europe up 12%, or 600 basis points, above market. China was up 29%, significantly above market. The segment posted operating margin of 24.4%, down 200 basis points compared to the year ago same period.

Illinois Tool’s Food Equipment revenue was almost flat at $497 million for Q1 2017, while it grew 2% organically. North America was up 1%, with stable demand for equipment up 2%. Internationally, both equipment and service were up 3%. The segment’s operating margin improved 60 basis points to 25.1%.

During Q1 2017, Illinois Tool’s Test & Measurement and Electronics revenue jumped 4% to $480 million, while on an organic basis revenue by grew 6%, with strong demand in semiconductor-related end markets. In Test & Measurement’s Instron business, where demand is tied more closely to business investment, organic growth was up 5%. The segment’s operating margin improved 450 basis points to 20.0%. The 20% includes 350 basis points of the noncash expense associated with amortizing acquisition-related intangible assets.

Illinois Tool’s Welding segment’s revenue declined 1% to $387 in Q1 2017, while organic growth was flat, which is a significant improvement versus a decrease of 8% in Q4 2016. Excluding normal seasonality, demand improved 3% sequentially. On a geographical basis North America, which generates approximately 80% of the segment’s business, was up 2%, driven by the Company’s commercial equipment business. Welding segment’s operating margin was the highest in the Company at 27.7% up 380 basis points.

For Q1 2017, Illinois Tool’s Polymers & Fluids delivered revenue growth of 2% generating sales of $426 million. The segment’s fluids unit, which primarily sells highly engineered lubricants and cleaners into industrial and commercial end markets, and Automotive Aftermarket grew 2%. Polymers, which primarily sells adhesives and sealants for industrial MRO and other OEM applications, was essentially flat. Operating margin was 20.6%, which includes 420 basis points of noncash expense associated with amortizing acquisition-related intangible assets.

Illinois Tool’s Construction Products revenue grew 3% organically to $395 million. Demand in North America was solid, with organic growth down 2% on a y-o-y basis. Commercial was down 1% and residential was down 2%. Operating margin improved 150 basis points to 22.5%. The Company’s Specialty Products sales declined 1% to $463 million, while on an organic basis revenue was up 1%, with strong organic growth of 8% in the divisions consumer packaging businesses. Operating margin was 26.9%, an increase of 80 basis points.

Outlook and Key Planning Assumptions

As a result of the Company’s strong results, Illinois Tool’s raised its 2017 full-year guidance. The Company now expects earnings to be in the range of $6.20 to $6.40 per share, up from prior guidance of $6.00 to $6.20 per share, with organic growth of 2% to 4%, up from 1.5% to 3.5%. The Company expects operating margin to exceed 23.5% and free cash flow to exceed 100% of net income. For Q2 2017, Illinois Tool’s is predicting earnings to be in the range of $1.55 to $1.65 per share with organic growth of 2% to 4%.

Stock Performance

At the close of trading session on Wednesday, April 26, 2017, Illinois Tool Works’ share price finished yesterday’s trading session at $139.14, slightly down 0.09%. A total volume of 1.94 million shares exchanged hands, which was higher than the 3 months average volume of 1.33 million shares. The stock has advanced 24.28% and 34.81% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 14.18%. The stock is trading at a PE ratio of 24.40 and has a dividend yield of 1.87%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460780

GRAND RAPIDS, MI / ACCESSWIRE / April 27, 2017 / According to U.S. Census
Bureau data, 75% of divorced people will eventually remarry, with 65% of them bringing children from a previous union. For many older Americans in second marriages, the prospect of future long term care needs is an issue that should be considered early because there are considerable financial risks involved, even if the partners have signed a prenuptial agreement. Shawn Weera, a Michigan attorney recognized as a specialist in elder law, has offered some important advice on the topic.

“Prenuptial agreements are completely ignored by the government when calculating Medicaid benefits,” says Shawn Weera, “While many couples in a second marriage might think that they have separated their assets, this is not the case. What it means is that the property and resources of the spouse remaining at home will be used to determine whether benefits will be paid, and further, it could mean that the healthy spouse will see their assets dramatically reduced by long term care expenses.”

Medicaid rules state that the spouse of a nursing home resident (called the “community spouse”) may keep one half of the couple’s joint assets up to $119,220 (2016 rules) – meaning that despite any prenuptial agreement, the community spouse could be required to pay for all long term care costs until their assets are reduced down to $119,220 before being entitled to Medicaid benefits. It is good to note that the applicant’s home will not be considered a countable asset for eligibility purposes, provided the equity in the home is less than $552,000, although in certain states, that may be as high as $828,000.

The way to deal with this is though advanced planning. Couples should consider adopting an asset protection trust while their health is good to avoid the Medicaid “Spend Down Rules.” With an asset protection trust, a spouse’s resources can be preserved for their family and potentially also keep the intent and effect of any existing prenuptial agreement intact. Due to the Medicaid look back rule, planning should be done as soon as possible, because any uncompensated transfers, such as transfers to a trust, must be done a full 60 months before a spouse needs to apply for Medicaid benefits. If there is not enough time to comply with the 60 month look back rule, it may still be possible to preserve part of the community spouse’s assets, but in general crisis planning such as this can cost twice as much as advanced planning, with fewer assets protected.

Nationally-recognized elder law expert Shawn Weera, JD, MFP, is a licensed attorney in private practice, who for more than a decade has assisted thousands of families deal with the many issues associated with retirement, social security, probate and estate taxes and helping wartime veterans and their spouses receive special benefits to help pay for in-home care. For 15 years, he has been helping retirees protect their assets through efficient and wise planning. Recognizing that each client has unique goals and situations, he shuns the “cookie-cutter” approach and develops particular and highly implementable strategies to provide long-term security and peace of mind.

Shawn Weera – Michigan Elder Law Attorney: http://shawnweeranews.com
Shawn Weera – YouTube: https://www.youtube.com/channel/UC10S3-DkSZrdNlILyUvxYag
Shawn Weera – Discusses IRA Beneficiary Trusts: http://finance.yahoo.com/news/shawn-weera-discusses-ira-beneficiary-005200612.html

Contact Information:

ShawnWeeraNews.com
http://shawnweeranews.com
contact@shawnweeranews.com

SOURCE: Shawn Weera

ReleaseID: 460751

Upcoming AWS Coverage on WEYCO Group Post-Earnings Results

LONDON, UK / ACCESSWIRE / April 27, 2017 / Active Wall St. blog coverage looks at the headline from Deckers Outdoor Corp. (NYSE: DECK) as the Company announced on April 25, 2017, that its Board of Directors has initiated a process to review a broad range of strategic alternatives. The review process includes an exploration and evaluation of strategic alternatives to enhance stockholder value, which may also include a sale or other transaction. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Deckers Outdoor’s competitors within the Textile – Apparel Footwear & Accessories space, WEYCO Group, Inc. (NASDAQ: WEYS), announced on April 10, 2017, that it will release its Q1 2017 financial results after the close on Tuesday, May 02, 2017. AWS will be initiating a research report on WEYCO in the coming days.

Today, AWS is promoting its blog coverage on DECK; touching on WEYS. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Details of the Agreement

Deckers Outdoor is a leading global designer, marketer, and distributor of innovative footwear, apparel, and accessories, with sales operations in more than 50 countries. Recently, on April 11, 2017, reports originated that Deckers Brands has hired the law firms, Wilson, Sonsini, Goodrich & Rosati to advise on defense strategy. Additionally, the Company had been speaking to banks where the talk was focused on strategic alternatives.

The Company has made significant progress in streamlining its cost structure, and optimizing the retail store fleet, to generate stable cash flow with minimum expenses. Additionally, Deckers Outdoor has been realigning the brands with the goal to achieve greater profitability. The Company recently launched a $150 million savings program and expects to drive improvements in its business, through the fund.

Additionally, Deckers Outdoor continues to explore additional margin-enhancing opportunities with its Board of Directors focused on enhancing stockholder value and a commitment to pursue the right course of action for all stockholders. The Company expects now to be the appropriate time to pursue a broad range of strategic alternatives that may have a potential to unlock further value.

The UGG Brand

The UGG brand is the flagship sheepskin boots brand from the house of Deckers Outdoor and it makes about 80% of the Company’s annual sales. The UGG brand has its own set of followers where plenty of fans love the big signature boots, while there are others who swear never to wear them. The flagship has witnessed criticism lately owing to designs outside the traditional boot.

Sales of Decker’s sheepskin UGG boots, popular across US cities, college campuses, and malls, exploded to $1.52 billion in FY16 from $37 million in FY03. However, growth has slowed and Deckers Outdoor’s share price has lost more than a third of its value since the end of 2014.

Stock Performance

At the closing bell, on Wednesday, April 26, 2017, Deckers Outdoor’s stock jumped 3.08%, ending the trading session at $60.55. A total volume of 1.84 million shares were traded at the end of the day, which was higher than the 3-month average volume of 1.12 million shares. In the last month and previous six months, shares of the Company have advanced 7.15% and 13.20%, respectively. Moreover, the stock gained 9.32% since the start of the year. At Wednesday’s closing price, the stock’s net capitalization stands at $1.94 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460779

LONDON, UK / ACCESSWIRE / April 27, 2017 / Active Wall St. blog coverage looks at the headline from The Medicines Co. (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY). On April 26, 2017, Medicines Co. (“MDCO”) and Alnylam Pharma announced that MDCO has received final, End-of-Phase II meeting minutes from the US Food and Drug Administration (FDA). MDCO has agreed with the FDA regarding plans for the Phase III clinical program for Inclisiran, designed to support the submission of a New Drug Application (NDA). Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

Today, AWS is promoting its blog coverage on MDCO and ALNY. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

What is Inclisiran?

Inclisiran, which was previously known as PCSK9si and ALN-PCSsc is an investigational GalNAc-conjugated RNAi therapeutic targeting PCSK9 – a genetically validated protein regulator of LDL receptor metabolism. This is being developed for the treatment of hypercholesterolemia. In contrast to anti-PCSK9 monoclonal antibodies that bind to PCSK9 in blood, Inclisiran is a first-in-class investigational medicine that acts by turning off PCSK9 synthesis in the liver.

Design of Phase III Program

MDCO’s Phase III program will comprise clinical trials in subjects with atherosclerotic cardiovascular disease (ASCVD) and familial hypercholesterolemia (FH). The Company will collectively enroll approximately 3,000 subjects randomized to treatment with Inclisiran (1,500) or placebo (1,500). The primary endpoint for all pivotal trials will be LDL-C change from baseline. MDCO stated that the subjects will be studied for 18 months. The dose of Inclisiran will be 300 mg given subcutaneously on day-1, day-90, and then every six months thereafter.

MDCO will also perform a cardiovascular outcomes trial in approximately 14,000 subjects with ASCVD and/or risk equivalents, such as diabetes, to determine the effects of LDL-C lowering with Inclisiran on cardiovascular outcomes. The design of the outcomes trial has also been agreed with the FDA and the primary efficacy endpoint of the trial will be a composite of coronary heart disease death, non-fatal myocardial infarction and fatal and non-fatal ischemic stroke. MDCO noted that the duration of the outcomes trial will be long enough to accumulate a sufficient number of events to provide overwhelming statistical power to ascertain treatment group differences and maximize the clinical effect size associated with LDL-C lowering. If the results exceed the primary end point target, the outcomes trial will be submitted to the FDA as a supplemental NDA.

“We are grateful to the FDA for its expertise, advice and support. Cardiovascular disease is a serious threat to the health of Americans, and it is clear that the FDA is committed to facilitating the development and approval of effective and safe drugs to address this important public health problem,” said Clive Meanwell, M.D., Ph.D., CEO of The Medicines Company, “Based on data from our Phase II ORION-1 study and the previous Phase I study – both published in The New England Journal of Medicine – we are confident that Inclisiran reduces LDL-C meaningfully. We believe our agreement with the FDA on the Phase III clinical development program for Inclisiran is highly favorable and adds significantly to Inclisiran’s strategic value.”

“The Medicines Company’s agreement with the FDA supports a clear path forward for further Inclisiran development and regulatory review. Indeed, we’re pleased with the excellent progress made by our colleagues at The Medicines Company to advance this potential, innovative medicine to patients in need, and we intend to fully support them in their efforts,” said John M. Maraganore, Ph.D., Alnylam’s CEO.

MDCO and Alnylam Pharma have been collaborating in the advancement of Inclisiran pursuant to their 2013 agreement. Under terms of the agreement, Alnylam completed certain pre-clinical studies and the Phase I clinical study, with MDCO leading and funding the development of Inclisiran from Phase II forward, as well as potential commercialization.

Stock Performance

On Wednesday, April 26, 2017, the stock closed the trading session at $49.75, climbing 1.30% from its previous closing price of $49.11. A total volume of 3.18 million shares have exchanged hands, which was higher than the 3-month average volume of 2.01 million shares. Medicines Co.’s stock price rallied 43.00% in the last three months, 34.53% in the past six months, and 39.43% in the previous twelve months. Furthermore, on a year to date basis, the stock soared 46.58%. The stock currently has a market cap of $3.55 billion.

Alnylam Pharma’s share price finished yesterday’s trading session at $54.02, advancing 5.20%. A total volume of 808.19 thousand shares exchanged hands. The stock has surged 42.80% and 45.22% in the last three months and past six months, respectively. Furthermore, since the start of the year, shares of the Company have soared 44.28%. At Wednesday’s closing price, the stock’s net capitalization stands at $4.57 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460781

If You Could Go Back and Buy Priceline for $7.00, Would You?

MIAMI, FL / ACCESSWIRE / April 27, 2017 / Since TechCrunch.com explained why O2O commerce is a Trillion Dollar Opportunity, it has been the dominant buzz, heard from Silicon Valley to Wall Street. While many have been able to capitalize on it, nobody has been able to perfect it.

While there are no, “Trillion Dollar” companies, there are however Trillion Dollar industries. One of them is the Online to Offline commerce industry, or O2O. You could define it by saying, it is anything digital, that brings people to shop offline. Real world examples of this concept are Groupon, Inc. (GRPN), Open Table, which was acquired in June 2014 by The Priceline Group (PCLN), and now infamous Uber, and it’s approaching $70 billion valuation.

The writers who declared this a trillion-dollar industry, calculate it by stating that, the average American earns $40,000 per year and spends only 9% shopping online, leaving trillions of dollars floating around the local economy. This is great news for the local business owners but, the challenge they are faced with is how to ensure that it’s their business, that captures the sale?

According to studies conducted by the Consumer Barometer, over 60% of buyers research products online before buying them offline, and this is the key to making the O2O industry a “Trillion Dollar” industry. If the merchants can capture potential customers, when they are researching a product, online, they can position themselves, to acquire that sale, offline.

This is already a proven model among majors like Best Buy Co., Inc. (BBY), Apple, Inc. (AAPL), The Gap, Inc. (GPS), Home Depot, Inc. (HD) and many more. Their O2O platforms consists of purchasing online and picking up at the local store. This eliminates two burdens for consumers; first, it allows the consumer to touch, examine and if need be, try on the product prior to bringing it home, and second, it eliminates the hassle of online returns.

So how does the local merchant capitalize on this?

The data and historical trends indicate an extremely lucrative opportunity for a company who can successfully bridge the online world with the offline.

Enter Grey Cloak Tech, Inc. (OTC PINK: GRCK).
Just two weeks ago, Grey Cloak Tech, Inc. (OTC PINK: GRCK) completed the acquisition of ShareRails,
a provider of online-to-offline (O2O) e-commerce services which was valued at over $6.4 million
by Excel Management Systems.

ShareRails transforms local retailers’ inventory data into rich digital content that is then indexed by Google (GOOG) and other search engines. The ShareRails O2O cloud platform offers retail merchants inventory management, curation, and promotion features that can make products discoverable, drive foot traffic, and boost customer experience.

This is how it’s done. Take the inventory of the local merchants and index it with the search engines. Now when the consumers are researching products online, they are doing it through the local merchants’ commerce platform.

Grey Cloak Tech, Inc.’s (OTC PINK: GRCK) ShareRails creates digital product catalogs that enhance mall and merchant websites. Searchable Malls. The Shops at South Town is one of the most innovative shopping malls in Utah. Through the ShareRails’ O2O platform, they drive new customers to South Town mall stores and offer mall shoppers greater convenience, than shopping online.

ShareRails’s latest work is an innovative web and mobile solution that connects consumers to a community of reputable Marie Claire stylists. Consumers receive personalized style recommendations and purchase directly through the shoppable content.

Grey Cloak Tech, Inc. (OTC PINK: GRCK), is posturing to become a major disruptor in this trillion-dollar O2O industry. Heading up GRCK, you’ll find Joseph Nejman, a Harvard graduate who served in a variety of business development roles at Google, as well as led the incubator at Google’s Eric Schmidt’s prominent venture capital firm, TomorrowVentures. Further, he sourced and led the investment in Marker Studios, which was acquired by Disney, (DIS) for approximately $1 billion.

With less than 75 million shares outstanding and a market cap of under $7 million, it’s hard to imagine the majors not competing for GRCK soon. Grey Cloak Tech, Inc. (OTC PINK: GRCK) is an SEC, current, reporting, company which currently trades on the OTC market. It will be interesting to see how quickly the company can ramp up and take the industry by storm.

About Emerging Growth

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://emerginggrowth.com/4725-4739/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Contact: info@EmergingGrowth.com

SOURCE: Emerging Growth.com

ReleaseID: 460750

WASHINGTON, DC / ACCESSWIRE / April 27, 2017 / The International Biometrics + Identity Association (IBIA), the preeminent trade organization for the identity technology industry, is proud to announce that Kevin McAleenan, the Acting Commissioner of U.S. Customs and Border Protection (CBP), is the opening keynote speaker at its Washington, DC ‘connect:ID’ Conference and Exposition, May 1-3, 2017. The Commissioner will address, “CBP’s commitment to innovation: Revolutionizing border security through technology,” on Monday, May 1 at 12:55 PM.

Mr. McAleenan has been the Acting Commissioner of CBP since January 2017, and was nominated by President Trump to head the agency at the end of March. CBP is the largest law enforcement agency and the second largest revenue collecting source in the federal government. According to Tovah LaDier, IBIA Managing Director, “Acting Commissioner McAleenan’s address on harnessing technology innovation to enhance border security will be of great interest to the technology leaders and others in the ‘connect:ID’ audience.”

Prior to his appointment as Acting Commissioner, Mr. McAleenan served as CBP’s Deputy Commissioner, performing as the agency’s Chief Operating Officer and senior career official. He has previously held a number of leadership positions within CBP and a predecessor agency, the U.S. Customs Service. Mr. McAleenan’s service to the U.S. is exceptionally distinguished, as evidenced by his receiving the nation’s highest civil service award, the Presidential Rank Award, in 2015. In 2005, he received the Service to America Call to Service Award for spearheading efforts to develop and implement a comprehensive border security antiterrorism strategy after the terrorist attacks of September 11, 2001.

‘connect:ID’ is the preeminent conference and expo where industry, government, and consumers join together to see the latest innovations and discuss the policy and technology issues that shape the concepts of identity. Produced by IBIA and Science Media Partners (SMP), ‘connect:ID’ will be held at the Walter E. Washington Convention Center in Washington, D.C. The conference runs May 1-3. Learn more at www.connectidexpo.com.

About IBIA:

IBIA advances the adoption and responsible use of technology based identification solutions to enhance security and privacy and to facilitate productivity and convenience for government, businesses, and consumers. For more information, please visit our website www.ibia.org.

Media enquiries for IBIA:

Tovah Ladier
ibia@ibia.org

Media enquiries for CBP:

Jennifer Gabris
jennifer.gabris@cbp.dhs.gov
202-344-1355

SOURCE: The International Biometrics + Identity Association

ReleaseID: 460724

TORONTO, ON / ACCESSWIRE / April 27, 2017 / Jaguar Financial Corporation (TSXV: JFC) (“Jaguar” or the “Company”) is pleased to announce that it has plans to do a consolidation of its common shares (each, a “Share”) on the basis of ten (10) pre-consolidation for one (1) post-consolidation Share (the “Consolidation”).

In connection with the consolidation, the name of the company will not change and the Company’s trading symbol will remain JFC. The share consolidation is subject to approval by the TSX Venture Exchange and the Company’s shareholders.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Jaguar Financial Corporation

Jaguar is a Canadian merchant bank that generally invests in undervalued, overlooked and underappreciated public companies where Jaguar determines that one or more changes could be made to create shareholder value.

For additional information on this press release, please contact:

Vic Alboini, Chairman & Chief Executive Officer
Jaguar Financial Corporation
416-483-3760

SOURCE: Jaguar Financial Corporation

ReleaseID: 460783